Paxlyte 64661-0217-30
Generic: Leucovorin, Folic Acid, Levomefolate Magnesium, Ferrous Cysteine Glycinate, 1,2-Docosahexanoyl-Sn-Glycero-3-Phosphoserine Calcium, 1,2-Icosapentoyl-Sn-Glycero-3-Phosphoserine Calcium, Phosphatidyl Serine, Pyridoxal 5-Phosphate, Flavin Adenine Dinucleotide, Nadh, Cobamamide, Cocarboxylase (thiamine Pyrophosphate), Magnesium Ascorbate, Zinc Ascorbate, Magnesium L-Threonate And Betaine Capsule
- Manufacturer
- Jaymac Pharmaceuticals
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 1, 2024
- Listing Expires
- December 31, 2026
Need to source Paxlyte? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| 1,2-Docosahexanoyl-Sn-Glycero-3-Phosphoserine Calcium | 6.4 mg/1 |
| 1,2-Icosapentoyl-Sn-Glycero-3-Phosphoserine Calcium | 800 ug/1 |
| Betaine | 500 mg/1 |
| Citric Acid Monohydrate | 1.83 mg/1 |
| Cobamamide | 50 ug/1 |
| Cocarboxylase | 25 ug/1 |
| Ferrous Cysteine Glycinate | 13.6 mg/1 |
| Flavin Adenine Dinucleotide | 25 ug/1 |
| Folic Acid | 1 mg/1 |
| Leucovorin | 2.5 mg/1 |
| Levomefolate Magnesium | 7 mg/1 |
| Magnesium Ascorbate | 24 mg/1 |
| Magnesium L-Threonate | 1 mg/1 |
| Nadh | 25 ug/1 |
| Phosphatidyl Serine | 12 mg/1 |
| Pyridoxal Phosphate Anhydrous | 25 ug/1 |
| Sodium Citrate | 1.83 mg/1 |
| Zinc Ascorbate | 1 mg/1 |
Drug Class
Methylating Agent [EPC]Folate Analog [EPC]Acidifying Activity [MoA]
Selected Package
64661-0217-30Selected30 CAPSULE in 1 BOTTLE (64661-217-30)
External Resources